A MULTI-CENTER, NONRANDOMIZED PHARMACOKINETIC STUDY OF MAKENA (HYDROXYPROGESTERONE CAPROATE INJECTION, 250 MG/ML) AND ITS METABOLITES IN BLOOD AND URINE OF WOMEN WITH A SINGLETON PREGNANCY AND A PREVIOUS SINGLETON SPONTANEOUS PRETERM DELIVERY